Literature DB >> 10885730

Evaluation of N-succinyl-chitosan as a systemic long-circulating polymer.

Y Kato1, H Onishi, Y Machida.   

Abstract

The water-soluble, low toxic and less biodegradable chitosan derivative N-succinyl-chitosan (Suc-chitosan) was investigated for body distribution and urinary excretion on a long-time scale (24-72 h after i.v. injection) using a fluorescein-labeling technique. Fluorescein isothiocyanate (FITC)-labeled Suc-chitosan (Suc-chitosan-FTC) was characterized for molecular weight, succinylation degree and FTC content. Systemic retention and tissue distribution of Suc-chitosan-FTC were examined after i.v. administration to normal and Sarcoma 180 tumor-bearing mice. Suc-chitosan-FTC was sustained at a high level in the circulation over 72 h; that is, the plasma half-life in normal mice was 100.3 h and that in tumor-bearing mice was 43.0 h, which was longer than those of other long-circulating macromolecules reported to date. As to the tissues except blood circulation, Suc-chitosan-FTC was distributed very little in tissues other than the tumor. Although the total amount of Suc-chitosan-FTC residing in tested tissues decreased gradually, urinary excretion did not increase from 24 h after injection. These observations suggested that Suc-chitosan-FTC may be eliminated by mechanisms other than in the urine or moved to tissues other than those tested. The ratio of tumor accumulation reached a plateau at 48 h after injection, and the accumulation level, approximately 10%, was similar to those observed for other reported long-circulating macromolecules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885730     DOI: 10.1016/s0142-9612(00)00044-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

Review 1.  Chitin and chitosan: biopolymers for wound management.

Authors:  Rita Singh; Kirti Shitiz; Antaryami Singh
Journal:  Int Wound J       Date:  2017-08-10       Impact factor: 3.315

Review 2.  The janus facet of nanomaterials.

Authors:  Julianna Kardos; Katalin Jemnitz; István Jablonkai; Attila Bóta; Zoltán Varga; Júlia Visy; László Héja
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

Review 3.  Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action.

Authors:  Hari Sharan Adhikari; Paras Nath Yadav
Journal:  Int J Biomater       Date:  2018-12-30

4.  Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery.

Authors:  Natallia V Dubashynskaya; Anton N Bokatyi; Alexey S Golovkin; Igor V Kudryavtsev; Maria K Serebryakova; Andrey S Trulioff; Yaroslav A Dubrovskii; Yury A Skorik
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

5.  Human serum albumin conjugates of 7-ethyl-10-hydroxycamptothecin (SN38) for cancer treatment.

Authors:  Nima Sepehri; Hasti Rouhani; Ahmad Reza Ghanbarpour; Mehdi Gharghabi; Faranak Tavassolian; Mohsen Amini; Seyed Nasser Ostad; Mohammad Hossein Ghahremani; Rassoul Dinarvand
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.